Literature DB >> 23640491

CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases.

Jun Hee Lee1, Sang Hun Lee, So Young Yoo, Takayuki Asahara, Sang Mo Kwon.   

Abstract

OBJECTIVE: Although endothelial progenitor cells (EPCs) have been reported to promote neovessel formation during vascular injury, the function of supporting cells of EPCs and their interaction with EPCs during EPC isolation remain unclear. APPROACH AND
RESULTS: We investigated the functional properties of 2 types of EPCs, also known as endothelial colony-forming cells (ECFCs), CD34(-)/CD34(+) cell-derived ECFCs (hybrid-dECFCs) and CD34(+) cell-derived ECFCs (stem-dECFCs), isolated using different methods, to elucidate the role of CD34(-) cell populations as cell-supporting niches. Using EPC colony-forming and insert coculture assays, we found that CD34(-) accessory cells dynamically modulate hematopoietic stem cell-derived endothelial cell progenitor commitment via angiogenic cytokines secreted by CD34(-)/CD11b(+) macrophages. On the basis of these findings, we isolated 2 types of ECFCs and investigated their bioactivities. We found that stem-dECFCs showed remarkably retarded cell growth, enhanced senescence, and decreased characteristics of ECFCs, whereas hybrid-dECFCs showed greater proliferative properties but delayed senescence. In a murine hind-limb ischemia model, hybrid-dECFCs showed significantly enhanced blood perfusion, capillary density, transplanted cell survival and proliferation, and angiogenic cytokine secretion compared with stem-dECFCs. In particular, the migratory capacity of hybrid-dECFCs was significantly enhanced, in part mediated via an augmented phosphorylation cascade of focal adhesion kinase and Src, resulting in a highly increased incorporation capacity of hybrid-dECFCs compared with stem-dECFCs. CD34(-) accessory cells of hybrid-dECFCs might be niche-supporting cells that facilitate cell survival, increase the secretion of angiogenic cytokines, and increase incorporation.
CONCLUSIONS: This study provided important insight into blood vessel formation and repair in ischemic diseases for ECFC-based cell therapy.

Entities:  

Keywords:  CD34; endothelial progenitor cells; hind-limb ischemia; niche-supporting cells; vascular repair; vasculogenesis

Mesh:

Substances:

Year:  2013        PMID: 23640491     DOI: 10.1161/ATVBAHA.112.301052

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  20 in total

Review 1.  Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine.

Authors:  Dewi Sukmawati; Rica Tanaka
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

2.  Endothelial Colony-Forming Cell Function Is Reduced During HIV Infection.

Authors:  Samir K Gupta; Ziyue Liu; Emily C Sims; Matthew J Repass; Laura S Haneline; Mervin C Yoder
Journal:  J Infect Dis       Date:  2019-03-15       Impact factor: 5.226

Review 3.  Injectable biomaterial shuttles for cell therapy in stroke.

Authors:  Juhi Samal; Tatiana Segura
Journal:  Brain Res Bull       Date:  2021-08-12       Impact factor: 3.715

Review 4.  Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and Challenges.

Authors:  Mark Seow Khoon Chong; Wei Kai Ng; Jerry Kok Yen Chan
Journal:  Stem Cells Transl Med       Date:  2016-03-08       Impact factor: 6.940

Review 5.  Regenerative principles enrich cardiac rehabilitation practice.

Authors:  Atta Behfar; Andre Terzic; Carmen M Perez-Terzic
Journal:  Am J Phys Med Rehabil       Date:  2014-11       Impact factor: 2.159

Review 6.  Cell therapy for cardiac repair--lessons from clinical trials.

Authors:  Atta Behfar; Ruben Crespo-Diaz; Andre Terzic; Bernard J Gersh
Journal:  Nat Rev Cardiol       Date:  2014-03-04       Impact factor: 32.419

7.  Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number.

Authors:  Alberto Lo Gullo; Giuseppe Mandraffino; Gianluca Bagnato; Caterina Oriana Aragona; Egidio Imbalzano; Angela D'Ascola; Francesco Rotondo; Antonella Cinquegrani; Enricomaria Mormina; Carlo Saitta; Antonio Giovanni Versace; Maria Adriana Sardo; Renato Lo Gullo; Saverio Loddo; Antonino Saitta
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

8.  Hypoxia accelerates vascular repair of endothelial colony-forming cells on ischemic injury via STAT3-BCL3 axis.

Authors:  Sang Hun Lee; Jun Hee Lee; Yong-Seok Han; Jung Min Ryu; Yeo Min Yoon; Ho Jae Han
Journal:  Stem Cell Res Ther       Date:  2015-07-29       Impact factor: 6.832

9.  Combination of CD34-positive cell subsets with infarcted myocardium-like matrix stiffness: a potential solution to cell-based cardiac repair.

Authors:  Shuning Zhang; Xin Ma; Kang Yao; Hong Zhu; Zheyong Huang; Li Shen; Juying Qian; Yunzeng Zou; Aijun Sun; Junbo Ge
Journal:  J Cell Mol Med       Date:  2014-06-19       Impact factor: 5.310

10.  Deciphering the in vivo Dynamic Proteomics of Mesenchymal Stem Cells in Critical Limb Ischemia.

Authors:  Yipeng Du; Xiaoting Li; Wenying Yan; Zhaohua Zeng; Dunzheng Han; Hong Ouyang; Xiudi Pan; Bihui Luo; Bohua Zhou; Qiang Fu; Dongfeng Lu; Zheng Huang; Zhiliang Li
Journal:  Front Cell Dev Biol       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.